Page last updated: 2024-08-26

fulvestrant and em 800

fulvestrant has been researched along with em 800 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bélanger, A; Caron, B; Cloutier, J; Dory, YL; Favre, A; Gauthier, S; Labrie, C; Labrie, F; Larouche, D; Leblanc, G; Mailhot, J; Martel, C; Mérand, Y; Ouellet, C; Schwerdtfeger, A; Simard, J1
Bellavance, E; Luu-The, V; Poirier, D1
Belanger, A; Gauthier, S; Labrie, C; Labrie, F; Merand, Y; Poirier, D; Sanchez, R; Simard, J; Singh, SM1
Giguère, V; Labrie, C; Labrie, F; Tremblay, A; Tremblay, GB1
Bélanger, A; Candas, B; Gauthier, S; Labrie, C; Labrie, F; Li, X; Martel, C; Mérand, Y; Provencher, L1
Jordan, VC; Liu, H; Schafer, JI; Tonetti, DA1
Elkak, AE; Mokbel, K1

Reviews

1 review(s) available for fulvestrant and em 800

ArticleYear
Pure antiestrogens and breast cancer.
    Current medical research and opinion, 2001, Volume: 17, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Benzopyrans; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Piperidines; Polyunsaturated Alkamides; Propionates

2001

Other Studies

6 other study(ies) available for fulvestrant and em 800

ArticleYear
(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.
    Journal of medicinal chemistry, 1997, Jul-04, Volume: 40, Issue:14

    Topics: Administration, Oral; Animals; Benzopyrans; Binding, Competitive; Breast Neoplasms; Cytosol; Diethylstilbestrol; Estradiol; Estrogen Antagonists; Female; Humans; Mice; Molecular Structure; Ovariectomy; Piperidines; Propionates; Raloxifene Hydrochloride; Receptors, Estrogen; Stereoisomerism; Structure-Activity Relationship; Uterus

1997
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
    Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23

    Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity

2009
Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells.
    Cancer research, 1997, Aug-15, Volume: 57, Issue:16

    Topics: Adenocarcinoma; Alkaline Phosphatase; Benzopyrans; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Neoplasm Proteins; Piperidines; Propionates; Raloxifene Hydrochloride; Tamoxifen; Toremifene; Tumor Cells, Cultured

1997
EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta.
    Endocrinology, 1998, Volume: 139, Issue:1

    Topics: Animals; Benzopyrans; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Genes, ras; Mice; Mice, Inbred C57BL; Propionates; Receptors, Estrogen; Transcription, Genetic

1998
Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
    Endocrinology, 1998, Volume: 139, Issue:5

    Topics: Animals; Benzopyrans; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Female; Fulvestrant; Mice; Mice, Inbred BALB C; Organ Size; Ovariectomy; Propionates; Receptors, Estrogen; Toremifene; Uterus; Vagina

1998
The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptor.
    Cancer research, 1999, Sep-01, Volume: 59, Issue:17

    Topics: Benzopyrans; Cell Division; Estradiol; Estrogen Antagonists; Fulvestrant; Humans; Piperidines; Propionates; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1999